Graves orbitoptathy Flashcards

1
Q

what is the incidence of graves orbitopathy

A

The estimated incidence of GO is 16 women or 3 men per 100,000 person per year

Prevalence: 400 000 people in the UK with GO

Compare with Type 2 diabetes:
One in ten people over 40 in theUKare now living with a diagnosis of Type 2diabetes

Prevalence: 3.4 million people in the UK with a diagnosis of Type 2diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the incidence of graves orbitopathy

A

The estimated incidence of GO is 16 women or 3 men per 100,000 person per year

Prevalence: 400 000 people in the UK with GO

Compare with Type 2 diabetes:
One in ten people over 40 in theUKare now living with a diagnosis of Type 2diabetes

Prevalence: 3.4 million people in the UK with a diagnosis of Type 2diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe the thyroid gland

A

Highly vascular endocrine organ
Lower neck anterior to trachea between the sternocleidomastoid muscles
Consists of densely packed follicles
Function
concentrates iodide to form thyroid hormones
Thyroid hormones synthesised and stored in the follicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does the thyroid hormone release

A

TRH stimulates release of TSH

TSH is secreted by the anterior pituitary and stimulates secretion of

T3 – Tri-iodothyronine

T4 - Tetra­-iodothyronine (Thyroxine)

T3 & T4 secreted into bloodstream:
bound to plasma proteins
free form - intracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the role of thyroid hormones

A

Growth and Development
rate of growth of many tissues
maturation of CNS and bones
regulation of synthesis of some respiratory enzymes
Metabolic Effects
regulation of basal metabolic rate
regulation of water and ion transport
regulation of calcium and phosphorus metabolism
regulation of cholesterol and fat metabolism
regulation of nitrogen metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is hyperthyroidism

A

Enlarged thyroid gland – goitre
Abnormal heart rhythms – tachycardia
Increased appetite but may have weight loss
Hand tremors
Fine brittle hair
Hyperactivity
Heat intolerance and increased perspiration – warm, moist skin
Lighter or less frequent periods
Irritability
Anxiety
Muscle weakness – upper arms and thighs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is hypothyroid (under active)

A

Fatigue, exhaustion
Feeling run down and sluggish
Unexplained / excessive weight gain
Dry, coarse, itchy skin and hair
Slow heart rate
Feeling cold – especially in the extremities
Goitre
More frequent periods, increased menstrual flow
Difficulty concentrating – brain fog
Hoarse voice
Muscle cramps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how to diagnose thyroid abnormalities

A

TSH – (considered outside normal if lower than 0.3 or higher than 3.0)

  1. Calculated free T4 index (10-20 pmol/L)
  2. Thyroid-stimulating immunoglobulin (TSI)
  3. Anti-thyroid antibodies
  4. Serum T3 (2.5 – 5.3 pmol/L)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the management for hyperthyroidism

A

Drug therapy

Radioactive iodine treatment

Thyroidectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what drugs are used for hyperthyroidism

A

Drug therapy
Thinomines (Carbimazole, Methamizole, Propylthiouracil) Interfere with thyroid hormone synthesis by blocking the build up of iodine. Most effective if the onset of disease within 1 year

Steroids (oral Prednisone) Decreases secretion of thyroid hormones and peripheral conversion of T4 and T3. Used in severe cases

Immunosuppressants (Azathioprine or Rituximab)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how is radioactive iodine used for hyperthyroidism

A

Radioactive iodine
- Radioactive iodine introduced to the body and taken up by the thyroid gland. Normal cell division and function is disturbed.
- Generally used on patients over 45 years of age or in younger patients if other treatments are contraindicated.
- 20% of patients become hypothyroid within 1 year of the treatment
- Ocular symptoms have been found to worsen following this treatment (Acharya 2008)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what does radioactive iodine and corticosteroids do in hyperthyroidsim

A

Prevents progression of GO in patients with pre-existing eye disease
Eye signs worsened in 6 months in:
15% after RI
2.7% after antithyroid drugs (carbimazole)
None who had RI and prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is a thyroidetomy in hyperhyroidism

A

removal of thyroid gland

Removal of most of the thyroid gland

Reduces hormone production

Post-op recurrence in 10-15% of patients

Post-op hypothyroidism in 40% of patients

Usually performed in younger patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what medication is given for hypothyroidism

A

oral thyroxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is graves disease

A

Graves’ disease is an autoimmune disorderthat causes hyperthyroidism. The immune systemattacks the thyroid and causes it to make more thyroid hormone than the body needs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what percentage of people with graves disease have graves orbitopathy

A

Approx 40% of GD have GO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

define graves orbitopathy

A

Auto-immune disease

Disease of the orbit affecting the orbital soft tissues

Closely correlated to auto-immune (systemic) thyroid disease (Graves’ Disease)

Prescence of circulating antibodies that bind and stimulate the thyroid hormone receptor (TSH) leading to hyperthyroidism and goitre.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are the risk factors for graves disease

A

Genetic

Environmental
Smoking
Stress

Immune factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what populations are most affected by graves orbitopathy

A

Male / female
female - 86%
16/10 000 women
3/10 000 men

Age
women 45-50 years
men 50-55 years (> severity)
Greater severity with age
(Lin et al 2008)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are the risk factors for smoking

A

Smoking
Main known risk factor 7-8 fold increase

Severity of eye signs and symptoms increased with increased tobacco consumption (Shine et al, 1990 Lancet)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what type of thyroid problem do most people with graves orbitopathy have

A

Hyperthyroidism 90%

Hypothyroid 3-5%

Euthyroid 5% ? Sensitivity of detection

Patients hyperthyroid without eye signs = 50-60%
80-90% have EOM changes on CT imaging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the natural history of graves orbitopaty

A

natural history is called bundles curve

active phase where their is inflammation for 1-3 years and then fibrosis = inactive phase 3 years and later where fibrosis occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what are the stages of graves orbitopathy

A

Wet / Congestive / Inflammatory / Active phase

Eyes are painful and red
Can last around 3 years

Dry / Fibrotic / Inactive phase

Eyes are white
Painless, restrictive myopathy may be present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is the history of graves orbitiopathy

A

Signs
Lid retraction
– 90-98%
Lid lag – von Graefe’s sign
Exophthalmos (proptosis)
Lid oedema
Periorbital oedema
Epiphora

Visual loss – Dysthyroid optic neuropathy DON ~5%
Chemosis
Strabismus – Eso/ Hypo
AHP
Thyroid disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what lid symptoms do people with graves have

A

upper lid , lower lid and palpebral appeture lid retraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

how to measure lid retraction

A

Position patient’s head correctly
Ask patient to fixate on target positioned at their eye level and in the distance.
Ask patient to relax as much as possible to record the minimum amount of retraction for that patient (i.e. Müller’s muscle as relaxed as possible).
Observer holds vertical clear plastic ruler near to visual axis without touching eyelashes
Observer should consistently use only one of their eyes, and on same horizontal level as patient’s eye.
For patients with manifest strabismus, the contralateral visual axis is occluded prior to measurement.
Record in mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what is used to measure exopthalomos/ propotosis

A

hertel mirrpor exopthalmoeter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what are the normal ranges for exopthalmost

A

12-21
12-33
12-20
12-24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what do you need to note when measuring exopthalmos

A

Bilateral
Asymmetric
Unilateral ?
Normal
exophthalmometry >22mm or
asymmetry greater than 3mm

Amount depends on severity of disease/ inflammation and structure of anterior orbital septum
Axial / non-axial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what happens during the wet/actve phase of ted

A

Wet phase – Active phase
Cellular infiltration with glycosaminoglycans (GAGs) and osmotic inhibition of water
This leads to EOMs becoming up to 8-10x enlarged
May compress ON leading to visual loss
Subsequent degeneration of muscle fibres leads to fibrosis resulting in restriced motility and diplopia

This phase tends to settle within 3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what happens to the eom during the dry/fibrotic phase

A

Fibrotic Phase / Dry Phase
Muscle fibres become distorted, contracted and damaged due to fibrosis
Eyes are white and quiet
Painless, restrictive myopathy may be present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what can be seen on a MRI of eom

A

enlarged by 10 times muscle but not tendon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what would you see on ocular movements

A

Limitation
Reversal
Saccades
Cog wheel pursuit
Fatigue
Pain
Retraction
Bilateral involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

what is the order of eom involvement

A

IR
MR
SR, LR
SO, IO (Thacker et al 2005)
Vertical, horizontal and torsional diplopia
Swelling of EOM results in restriction: if IR affected then pt unable to elevate as eye becomes tethered down

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

what can help diagnosis

A

mri scans can aid diagnosis

36
Q

what is graves orbitopathy

A

GO is an autoimmune condition diagnosed by blood tests along with clinical history and assessment

37
Q

how many phases of ted are there

A

3 phases

38
Q

what type of thyroid defect to people usually have with ted

A

Patients are usually hyperthyroid, but can be hypothyroid or euthyroid

39
Q

what position of gaze is usually affected

A

Upgaze typically affected first

Multiple distinctive eye signs
Can result in painful eye movements, diplopia or visual loss

40
Q

why is up gaze typically affected first

A

because of inferior rectus enlargement

41
Q

when can ted be diagnosed

A

TED can be diagnosed when two of the following three signs are present:

clinical orbital signs (lid retraction / proptosis / optic neuropathy)

laboratory tests (positive bloods for autoantibodies)

typical orbital imaging finding (swollen EOMs)

42
Q

what are the signs and symptoms of ted in the mild/early stage

A

symptons
Foreign body sensation;
dry eye; excessive tearing; conjunctival or eyelid redness
and swelling;
blurred vision;
retro-orbital pain

signs
Mild, soft tissue inflammation;
Dilated conjunctival vasculature;
keratoconjunctivitis;
corneal staining

43
Q

in moderate ted what are the signs and symptons

A

pulling sensation around the eye

eyelid redness and welling , eyelid retraction and bulging in the eyes

swelling of eom

chemises

eyelid oedema

proptosis

44
Q

what are the advanced symptoms of ted

A

Horizontal, vertical, and torsional
strabismus with double vision;
deteriorating blurred vision;
fading colour vision in one or both eyes;
decrease in visual acuity, visual field, and colour vision
(signs of optic neuropathy)

Progressive proptosis with eyelid retraction;
corneal ulceration;
inflammation of extraocular muscles and scarring leading to strabismus and
ophthalmoplegia;
increased intraocular pressure;

45
Q

what is the role of an orthoptist in ted

A

Diagnosis
Assessment of visual function
Document effects on ocular muscles
Record disease progress
Establish when ocular signs stabilise
Explanation and information and signposting
Eliminate symptoms / diplopia
Plan long term management
§

46
Q

what is needed in orthoptic investigation

A

Assess visual function
CT
Note any AHP
OM + measure PA
BSV tests (inc VPFR)
PCT + torsion (synoptophore or torsionometer)
Uniocular field of fixation
Field of BSV
?Lees screen / Hess (not useful in bilateral cases)

47
Q

what tests are done to assess visual function

A

contrast sensitivity

visual fields

pupils

48
Q

what are clinical signs of optic nerve compression

A

on compression = ocular emergency

reduced va

reduced cs

reduced colour vision

visual field defect

rapid - relative afferent pupillary defect

optic disc exam - normal/ serving / pallor

optic neuropathy - approx 5%

49
Q

what is a modified unioocualr field of fixation

A

This modified technique for measuring UFOF gives additional quantified information on the vertical extraocular muscles. Its reliability is equivalent to that of other measurement methods in healthy subjects and in those with restricted motility. It can be performed rapidly, minimizing patient discomfort, and may be particularly helpful in the sequential assessment of GO. The data on patients with GO suggest that a difference of 8° is required to detect significant change, particularly where several observers are involved, and this has important implications for the monitoring of GO, especially when using the CAS.

50
Q

what can graves orbitopathy be differenitally diagnosed

A

Acute presentation
Carotid-cavernous Fistula
Myositic pseudotumour
Ocular myositis
Leukemia see Pai et al 2011 for case study

Chronic presentation
Metastatic tumours
Lymphoma
Chronic progressive external ophthalmoplegia

Myasthenia
Fatigue
Variable ptosis
Limitation not persisting on FDT

51
Q

what is wrens classification of myasthenia

A

1 None
2 Only signs, no symptoms
3 Soft tissue involvement
4 Proptosis
5 Extraocular muscle involvement
6 Corneal involvement
7 Sight loss

52
Q

what is mouritis clinical activity score

A

First visit score only 1-7, review visits score 1-10
1. Painful oppressive feeling on or behind the globe in last 4 weeks
2. Pain on eye movement in last 4 weeks
3. Redness of eye lid
4. Diffuse redness on conjunctiva covering at least 1 quad
5. Swelling of lid (erythema)
6. Chemosis
7. Swollen caruncle
8. Increase in proptosis >2mm in 1-3 months
9. Reduced motility 5 degrees
10. Reduction in VA of 1 line with PH over 3 months

Mild: Mourits Activity score 4

Moderate: Mourits Activity 4-6

Severe: Mourits Activity 7 – 10 or presence of vision threatening signs (Exposure, optic nerve oedema, or RAPD

53
Q

how is graves classified by eugogo

A

sight threatening graves - patients with dysthyroid optic neuropathy and corneal breakdown

moderate to sever go - patients without sight threatening go whose eye disease has sufficient impact on daily life to justify the risks of immunosuppression or surgical intervention - patients with moderate or sever soft tissue involvement usually have one of the following lid retraction exothalmos

mild go - patients with mild have a minor impact - insuffiecnt for surgery , minor lid retraction/exopthalmos or soft tissue involevemt, corneal exposure responsive to lubricants

54
Q

what are the management options for people

A

Orthoptic / conservative

Surgical:
Sight saving
Strabismus
Lid

55
Q

what are the aims of orthoptic management

A

Preserve visual function

Keep patient comfortable and symptom free

Allow comfortable BSV in pp and reading position where possible

56
Q

what are the orthoptic management options for ahp

A

Encourage use of AHP

Prisms - temporary / incorporated

Occlusion – blenderm / patch / frosted lens

Surgery

BT

57
Q

what needs further imput from an opthalmologist (non urgently)

A

Non urgently

“Gritty” sensation and/or eyes sensitive to light
Progressive change in eye appearance

Pain in or behind the eyes

Diplopia

Eyelid retraction

Swelling/redness of eyelids and/or conjunctiva

Restriction of eye movement

Tilting of head to avoid double vision

58
Q

what needs further imput from an ophthalmologist (urgently)

A

Urgently

Sudden deterioration in vision

Problems with colour vision

Sudden onset proptosis

Failure of full eye closure

Corneal opacity

Abnormal disc possible described on referral optometrist/eye casualty

59
Q

what surgical intervention options are there for people with graves

A

ON compression – orbital surgery
2. Strabismus / ocular realignment surgery
3. Lid surgery

Multidisciplinary approach:
May involve maxillary facial surgeons, strabismologist and orbital surgeons

60
Q

what orbital changes occur to people with graves

A

Orbital changes

Retrobulbar adipose tissue is increased in volume and may have lymphocytic infiltrate.

Increased volume of orbital contents typically leads to exophthalmos

May lead to ON compression / neuropathy

61
Q

what can be done to treat optic neuropathy

A

steroids

radiation

orbital decompression

62
Q

what steroids are used and what are its indications for use

A

Mechanisms
anti-inflammatory
immune response - immunosuppressive
decrease mucopolysaccharide production by orbital fibroblasts

Indications
acute inflammatory disease
optic neuropathy - mild VA loss
recent onset <6m, predominantly severe soft tissue signs
following other treatments
pre / post decompression

63
Q

why is steroids and azathioprine prescribed

A

Another immunosuppressant
Allows reduction of steroid if prolonged large doses – reduces side effects of steroids
Effects modest

64
Q

what are the pros and cons of radiation therapy

A

Well tolerated

no short term side affects

usually no long term side affects

Reduces symptoms but not the course of the disease

Referral to oncologist

face mask to immobilise patient and allow accurate delivery of radiation

planning with CT

2 weeks of treatment delivered daily

50 centres, ? priority

65
Q

what is radiotherapy

A

reduce the cells which cause the inflammation and so reduce the swelling behind the eye.
It may take up to a year to notice the full effect.
ten radiotherapy treatments given over two weeks
face mask to immobilise patient and allow accurate delivery of radiation
Risk of cataract
Risk of dry eyes

66
Q

how is radiation therapy implemented

A

Daily doses of radiation beams directed at the orbital area
Low dose of 2Gy x ten days

Destroys lymphocytes and fibroblasts reducing auto-immune response

First weeks often in conjunction with steroids

Increased chemosis in first week of treatment

Improvement after 2 weeks of treatment

If no improvement in 1 month of treatment unlikely to improve

67
Q

in what type of patients is radiation therapy indicated

A

Indicated in patients with
severe acute soft tissue signs - (steroids initially as radiotherapy not immediate)
recent onset progressive proptosis
acute ophthalmoplegia
acute vision loss
where steroid treatment has failed

68
Q

what effect does radiotherapy treatment have - clincical activity score

A

Mourits 1997

Success of radiotherapy treatment

Patients with CAS > 4 = 80% chance of improvement

Patients with CAS < 4 = 36% chance of improvement

69
Q

what effect does radiotherapy treatment have - clincical activity score

A

Mourits 1997

Success of radiotherapy treatment

Patients with CAS > 4 = 80% chance of improvement

Patients with CAS < 4 = 36% chance of improvement

70
Q

what is orbital decompression and its indications for use

A

an operation to remove bone from the walls of the orbit (the eye socket) in order to reduce the amount of protrusion of the eye

Indications
sight threatening situations
Improve cosmesis (40%, Lyons & Rootman 1994)

71
Q

what are the types of orbital decompression

A

Lateral
2. Transantral
3. Transfrontal
4. Ethmoidal
5. Maxillary

72
Q

what type of orbital decompression is indicated for what disease

A

lateral orbital (single) for moderated

orbital fat decompression alone for mild proptosis

73
Q

what are the complications of orbital decompression

A

Temporary lip numbness Asymmetric correction of proptosis
Sinusitis* Apparent  upper lid retraction
Orbital cellulitis* Late endophthalmos
Meningitis* Epiphora
Lower lid entropian Diplopia
Blindness 1/10000

  • 10/7 antibiotics
74
Q

is there an advantage for early rehabilitative decompression

A

No advantage in having early rehabilitative decompression for aesthetics
Associated with higher risk of diplopia

75
Q

what are ted’s associations with strabismus

A

Occurs in 15-51% of patients with TED
Diplopia which impacts on work / driving / ability to function independently
Vertical

76
Q

what are indications for strabismus surgery

A

Medical condition stable
Eye condition stable
Problematic diplopia
Uncomfortable head posture
Centralise and / or enlarge field of BSV

77
Q

what eom surgery is done

A

Extraocular Muscle Surgery

Forced duction testing - pre, intra and post op
Recession of muscles, avoid resections
Free adhesions
Undercorrection
Adjustable sutures – allow fine tuning and adjustment of AHP
Inferior rectus dissected from attachments to lower lid
Inferior rectus recession
Medial rectus recessions

78
Q

when is surgery usually done

A

Six months stability”

In practice tend to wait longer until sure disease has stabilised

79
Q

what happens to the lids during surgery

A

Lid retraction (upper and lower lid)
Levator palpebral superioris - muscle fibre enlargement and oedema - rarely affects function
Overaction of Muller’s muscle (sympathetic overaction)
Innervation to SR and levator palpebral superioris

80
Q

how does drug effect lid retraction

A

Guanethidine
Topical (drops) alpha-adrenergic
blocking agent

Triamcinolone - oral
anti-inflammatory / anti-
fibrotic effect

81
Q

what procedures are done on people with lid retraction

A

Levator muscle procedures

Müller’s muscle procedures

Combination of above

Aim to leave ptotic - gradually elevates
Lateral tarsorrhaphy

rarely used now
not very effective
may prevent exophthalmos

82
Q

what levator muscle procedures would be done

A

Levator muscle procedures

recession

tenotomy

BT - Ozkan et al, 1997 4 patients (8 eyes)
effective for 3-4 months

Noah & Eckstein (2007) 5-15 IU BT to levator or Mullers muscle
Transient diplopia or ptosis in up to 20% cases

83
Q

what surgery is done for lid retraction

A

Lid retraction – Henderson’s operationWeakening of Müller’s muscle

84
Q

what is done for peri- orbital odema

A

Blepharoplasty (surgical correction of a lid deformity)
mark out excess skin
excise skin and orbicularis
remove fat

Complications
Infection
Bleeding
Dry / irritated eyes
Difficulty closing eyelids

85
Q

what can be done for the cornea

A

Tape lids
Glasses with side protection
hypromellose
Steroids
Orbital decompression
Tarsorraphy

86
Q

what is rituximab

A

Rituximab is a drug which depletes B cells promoting antibody-dependent cellular toxicity
It was used initially to treat non-Hodgkin B-cell lymphoma and more recently has benefited individuals with rheumatoid arthritis.

Sustained resolution of Optic neuropathy & inflamation
But
proptosis and strabismus were unimproved
by RTX

no sufficient evidence to support its effectiveness

87
Q

what is tepezza

A

New medicine to treat GO
Human monoclonal antibody
Approved for use in USA in Jan 2020
Expensive - $343000 per patient for 6 months of treatment (approx. £250k)

only medication that reduces the fat and muscle expansion within the orbit
Only medicine to possibly reduce ON compression
Some patients remain non-responders to treatment
Possible side effects: hearing loss, hyperglycemia, and muscle spasm